Ambu A/ S stock (DK0060946788): Shares edge higher in Copenhagen

Ambu A/S traded higher in Copenhagen on 05/29/2026, with the stock closing at kr67.40 after a 2.74% gain. Monday's context focuses on the research picture around the Danish medical device maker.

Ambu A/S shares rose 2.74% on the last trading day before month-end, closing at kr67.40 on 05/29/2026 in Copenhagen, according to StockInvest as of 05/29/2026. The move kept the Danish medtech name in focus on Nasdaq Copenhagen, where the stock has remained actively traded as investors track updates tied to the home market and the broader Nordic health care sector.

For a German-language readership, the share can also be followed on local venues such as Xetra when liquidity is available, but the home listing remains the primary reference point for Ambu A/S. A separate market data source put the stock's 52-week range at 60.5 to 111.8, underscoring how much ground the shares have covered over the past year.

As of: 06/01/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Ambu
• Sector/industry: Medical devices
• Headquarters/country: Ballerup, Denmark
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Single-use endoscopy solutions, airway management products, patient monitoring and diagnostics
• Home exchange/listing venue: Nasdaq Copenhagen (AMBU B)
• Trading currency: DKK

Ambu A/S: core business model

Ambu develops and sells single-use medical devices, with demand concentrated in endoscopy, anesthesia, and emergency care workflows across hospitals and clinical settings.

What banks and research houses say about Ambu A/S

No verified analyst coverage was identified at the time of publication.

That lack of a rendered bank snapshot does not change the core home-market setup: Ambu remains a Copenhagen-listed Danish medtech group, and the stock's daily trading range continues to be shaped more by product execution and hospital adoption trends than by any single broker call.

Conclusion

The latest move in Ambu A/S shares keeps the Danish medtech name on watch in Copenhagen, even without a new company announcement driving the session. Monday's analyst module did not surface a verified named-bank snapshot, so the stock's immediate narrative remains anchored in market trading and its Nordic home listing.

The broader setup is still defined by Ambu's single-use device portfolio and international hospital exposure, which makes demand trends and clinical adoption the main long-term swing factors rather than one-off headlines.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.